Cargando…
Correction: Sankaranarayanan et al. Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study. Cancers 2022, 14, 230
Autores principales: | Sankaranarayanan, Ramya Ambur, Peil, Jennifer, Vogg, Andreas T. J., Bolm, Carsten, Terhorst, Steven, Classen, Arno, Bauwens, Matthias, Maurer, Jochen, Mottaghy, Felix, Morgenroth, Agnieszka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177469/ https://www.ncbi.nlm.nih.gov/pubmed/37174130 http://dx.doi.org/10.3390/cancers15092641 |
Ejemplares similares
-
Auger Emitter Conjugated PARP Inhibitor for Therapy in Triple Negative Breast Cancers: A Comparative In-Vitro Study
por: Sankaranarayanan, Ramya Ambur, et al.
Publicado: (2022) -
PARP targeted Auger emitter therapy with [(125)I]PARPi-01 for triple-negative breast cancer
por: Ambur Sankaranarayanan, Ramya, et al.
Publicado: (2022) -
Correction: PARP targeted Auger emitter therapy with [(125)I]PARPi-01 for triple-negative breast cancer
por: Sankaranarayanan, Ramya Ambur, et al.
Publicado: (2023) -
Targeting of prostate-specific membrane antigen for radio-ligand therapy of triple-negative breast cancer
por: Morgenroth, Agnieszka, et al.
Publicado: (2019) -
Advancements in PARP1 Targeted Nuclear Imaging and Theranostic Probes
por: Ambur Sankaranarayanan, Ramya, et al.
Publicado: (2020)